换一批Symptom Improvement Following Treatment with the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in Patients with Moderate to Severe COPD - A Detailed Analysis.
第一作者：
Henrik,Watz
第一单位：
Pulmonary Research Institute at Lung Clinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany.
作者：
医学主题词
成年人(Adult);老年人(Aged);支气管扩张药(Bronchodilator Agents);双盲法(Double-Blind Method);女(雌)性(Female);用力呼气量(Forced Expiratory Volume);人类(Humans);异喹啉类(Isoquinolines);男(雄)性(Male);中年人(Middle Aged);磷酸二酯水解酶类(Phosphoric Diester Hydrolases);肺疾病, 慢性阻塞性(Pulmonary Disease, Chronic Obstructive);嘧啶酮类(Pyrimidinones);治疗结果(Treatment Outcome)
DOI
10.2147/COPD.S263025
PMID
32982212
发布时间
2024-03-29
- 浏览3
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
